The landscape of dementia diagnosis has progressed radically with the advent of complex biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent tests that could detect Alzheimer's pathology decades just before indications emerge. Although these technological advancements represent exceptional development in being familiar wit